Circulation · 2012 · 181 citations · 22 references
MedicineBiotechnologyCardiologyBiomedical ImagingRegenerative MedicineStem Cell BiologyAnimal Cell CultureEngraftment MonitoringMyocardial Perfusion ImagingMyocardial Viability ImagingCardiac Cell EngraftmentIn Vivo ImagingInduced Pluripotent Stem CellsIntramyocardial Cell AdministrationIodide UptakeMyocardial Infarction ImagingStem Cell TrackingTransgene Expression Imaging
BACKGROUND: Evaluation of novel cellular therapies in large-animal models and patients is currently hampered by the lack of imaging approaches that allow for long-term monitoring of viable transplanted cells. In this study, sodium iodide symporter (NIS) transgene imaging was evaluated as an approach to follow in vivo survival, engraftment, and distribution of human-induced pluripotent stem cell (hiPSC) derivatives in a pig model of myocardial infarction. METHODS AND RESULTS: Transgenic hiPSC lines stably expressing a fluorescent reporter and NIS (NIS(pos)-hiPSCs) were established. Iodide uptake, efflux, and viability of NIS(pos)-hiPSCs were assessed in vitro. Ten (±2) days after induction of myocardial infarction by transient occlusion of the left anterior descending artery, catheter-based intramyocardial injection of NIS(pos)-hiPSCs guided by 3-dimensional NOGA mapping was performed. Dual-isotope single photon emission computed tomographic/computed tomographic imaging was applied with the use of (123)I to follow donor cell survival and distribution and with the use of (99m)TC-tetrofosmin for perfusion imaging. In vitro, iodide uptake in NIS(pos)-hiPSCs was increased 100-fold above that of nontransgenic controls. In vivo, viable NIS(pos)-hiPSCs could be visualized for up to 15 weeks. Immunohistochemistry demonstrated that hiPSC-derived endothelial cells contributed to vascularization. Up to 12 to 15 weeks after transplantation, no teratomas were detected. CONCLUSIONS: This study describes for the first time the feasibility of repeated long-term in vivo imaging of viability and tissue distribution of cellular grafts in large animals. Moreover, this is the first report demonstrating vascular differentiation and long-term engraftment of hiPSCs in a large-animal model of myocardial infarction. NIS(pos)-hiPSCs represent a valuable tool to monitor and improve current cellular treatment strategies in clinically relevant animal models.
22
Genetic engineering of human pluripotent cells using TALE nucleases
Dirk Hockemeyer, Haoyi Wang, Samira Kiani et al. · Nature Biotechnology · 2011 · 1.1K citations
Generation of Induced Pluripotent Stem Cells from Human Cord Blood
Alexandra Haase, Ruth Olmer, Kristin Schwanke et al. · Cell stem cell · 2009 · 482 citations · Full text
Scalable expansion of human pluripotent stem cells in suspension culture
Robert Zweigerdt, Ruth Olmer, Harmeet Singh et al. · Nature Protocols · 2011 · 280 citations